Search

Search Results

• 

  Wegener´s granulomatosis in a young patient preceded by localized cutaneous manifestations

  Jesper Smit, Jakob Lykke Poulsen, Jakob Sølling, Carsten Sauer Mikkelsen

  e44

  27-10-2011

  https://doi.org/10.4081/dr.2011.e44

  1612

  PDF: 573

  HTML: 1604

• S-MAPA: bridging the gap in psoriasis severity assessment

  Trang Thi Thuy Vu, Chuyen Thi Hong Nguyen, Trung The Van

  28-05-2025

  https://doi.org/10.4081/dr.2025.10231

  751

  PDF: 357

  HTML: 33

• HLA-Cw6 increases the risk of psoriasis and early onset before twenty-seven years of age among the Vietnamese population

  Nhi Thi Uyen Pham, Thuong Van Nguyen, Hao Trong Nguyen

  16-10-2023

  https://doi.org/10.4081/dr.2023.9854

  1459

  PDF: 563

  HTML: 54

• Treatment satisfaction among patients with psoriasis in Saudi Arabia

  Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

  15-04-2024

  https://doi.org/10.4081/dr.2024.9967

  1132

  PDF: 648

  HTML: 51
• 

  Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

  Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

  29-12-2022

  https://doi.org/10.4081/dr.2023.9613

  1829

  PDF: 565

  HTML: 102
• 

  Churg-Strauss syndrome and hemorragic vasculitis

  Rui Moreira Marques, Ana Rita Cabral, Antonio Monteiro, Pedro Henriques

  e49

  02-12-2011

  https://doi.org/10.4081/dr.2011.e49

  1620

  PDF: 805

  HTML: 1085

• 26 | CONCOMITANT THERAPY WITH IXEKIZUMAB PLUS TIRZEPATIDE IN ADULTS WITH PSORIATIC ARTHRITIS AND OVERWEIGHT OR OBESITY DEMONSTRATED SUPERIOR DISEASE CONTROL COMPARED TO IXEKIZUMAB ALONE: RESULTS FROM THE PH3B TOGETHER-PSA TRIAL E. Filippi¹, J. F. Merola², P. Mease³, A. Kivitz⁴, N. Sattar⁵, L. C. Coates⁶, C. E. Kartman⁷, P. Fischer⁷, L. Sun⁷, A. Cardoso⁷, M. C. Genovese⁷, A. Ogdie⁸ | ¹Eli Lilly Italia S.p.A, Florence, Italy; ²Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; ³Providence Swedish Medical Center, Seattle, WA, USA; ⁴Altoona Center for Clinical Research, Duncansville, PA, USA; ⁵School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; ⁶Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; ⁷Eli Lilly and Company, Indianapolis, IN, USA; ⁸Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11088

  101

  PDF: 26
• 

  Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

  Federica Mola, Alberico Motolese

  e40

  03-10-2011

  https://doi.org/10.4081/dr.2011.e40

  1317

  PDF: 621

  HTML: 1091
• 

  Granuloma faciale in a patient with remitting seronegative symmetric synovitis with pitting edema

  Abdurhman Saud Al Arfaj, Najma Khalil, Malak Alzahrani, Sufia Husain

  22-05-2023

  https://doi.org/10.4081/dr.2023.9725

  810

  PDF: 406

  HTML: 25
• 

  Infections of scleroderma digital ulcers: A single center cohort retrospective study

  Dilia Giuggioli, Luca Magnani, Amelia Spinella, Gianluigi Bajocchi, Adalgisa Palermo, Federica Lumetti, Emanuele Cocchiara, Carlo Salvarani

  05-10-2021

  https://doi.org/10.4081/dr.2021.9075

  2426

  PDF: 515

  HTML: 15

• Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

  Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  12-11-2024

  https://doi.org/10.4081/dr.2024.10080

  1377

  PDF: 752

  HTML: 48
• 

  Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

  Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi

  01-10-2018

  https://doi.org/10.4081/dr.2018.7859

  2132

  PDF: 1099

  HTML: 89

• Anti-TIF-1γ-positive dermatomyositis associated with colorectal adenocarcinoma: a case report

  Sofia Spagnolini, Arlind Kalaja, Stefano Macchi, Ignazio Stanganelli, Maria Beatrice De Felici Del Giudice

  23-09-2025

  https://doi.org/10.4081/dr.2025.10489

  377

  PDF: 224

  HTML: 3
• 

  Evans’ syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma

  Thilo Gambichler, Pia Nordmann, Christina Scheel, Laura Susok

  21-11-2022

  https://doi.org/10.4081/dr.2022.9470

  1179

  PDF: 480

  HTML: 239

• The top 100 most cited articles in acne vulgaris: a bibliometric analysis

  Sapir Itzhaki Gabay, Barak Zlakishvili, Yuliya Valdman-Grinshpoun , Amir Horev

  15-02-2024

  https://doi.org/10.4081/dr.2024.9886

  3361

  PDF: 615

  SUPPLEMENTARY MATERIAL: 201

  HTML: 26

• Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

  Caterina Mariarosaria Giorgio, Eugenia Veronica Di Brizzi, Gaetano Licata, Carmine Fiorentino, Giuseppe Argenziano, Luca Damiani

  04-02-2025

  https://doi.org/10.4081/dr.2025.10232

  572

  PDF: 364

  HTML: 27
• 

  Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

  Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno

  28-12-2021

  https://doi.org/10.4081/dr.2022.9454

  4156

  PDF: 693

  APPENDIX: 198

  HTML: 20

• Venous thromboembolism in bullous pemphigoid: current evidence from an updated systematic review

  Atheer G. Almutairi, Abeer G. Almutairi, Rahaf R. Almutairi, Asem Shadid, Alhanouf A. Bin Dakhil, Lamia Alakrash

  29-01-2025

  https://doi.org/10.4081/dr.2025.10257

  903

  PDF: 418

  SUPPLEMENTARY MATERIAL: 91

  HTML: 12
• 

  Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

  Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

  22-05-2023

  https://doi.org/10.4081/dr.2023.9630

  1122

  PDF: 592

  HTML: 97
• 

  Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

  Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone

  29-07-2021

  https://doi.org/10.4081/dr.2021.8797

  3162

  PDF: 670

  HTML: 20

• Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

  Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

  11-11-2024

  https://doi.org/10.4081/dr.2024.10140

  1093

  PDF: 579

  SUPPLEMENTARY MATERIAL: 188

  HTML: 24

• Efficacy of a topical polyphenol-based formulation in palmoplantar psoriasis: an observational study

  Simone Amato, Annunziata Dattola, Luigi Bennardo, Martina Tolone, Steven Paul Nisticò

  08-07-2025

  https://doi.org/10.4081/dr.2025.10333

  554

  PDF: 376

  HTML: 36

• Mendelian randomization analysis of the causal relationship between immune cells and keloid

  Jingwen Zou, Pengkhun Nov, Kunpeng Du

  23-10-2024

  https://doi.org/10.4081/dr.2024.10106

  886

  PDF: 463

  SUPPLEMENTARY MATERIAL: 164

  HTML: 23
• 

  Atopic dermatitis: a brief review of recent advances in its management

  Sultan Daghafak Alenazi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9678

  2518

  PDF: 1454

  HTML: 128
• 

  An unusual case of Lyme borreliosis: can we miss it?

  Antigona Begolli Gerqari, Mybera Ferizi, Sadije Halimi, Albina Ponosheci, Arjeta Zogaj Berisha, Idriz Gerqari

  29-08-2019

  https://doi.org/10.4081/dr.2019.8021

  1318

  PDF: 802

  HTML: 32